United States set
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human Serum Amyloid A (SAA) ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA
  • Other names:PIG4, SAA1 and SAA2, TP53I4 serum amyloid A1 and serum amyloid A2
  • Species:Human
Cat. No. Size Price

New RBL008R 96 wells (1 kit) $526,55
PubMed Product Details
Technical Data


Sandwich ELISA


Serum, Plasma

Sample Requirements

5 µl/well


Shipped on blue ice packs. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Range

6.25 - 200 ng/ml

Limit of Detection

1.56 ng/ml

Intra-assay (Within-Run)

n = 8
CV = 9.5%

Inter-assay (Run-to-Run)

n = 8
CV =10.5%

Spiking Recovery


Dilution Linearity




It is intended for research use only

The total assay time is less than 3 hours

The kit measures specifically SAA1+SAA2 and there is no reactivity with (unsolicited) SAA3or SAA4

Assay format is 96 wells

Quality Controls are human serum based

Standard is a recombinant protein

Components of the kit are provided ready to use, concentrated or dried

Research topic

Coronary artery disease, Immune Response, Infection and Inflammation, Oncology, Transplantation


Serum amyloid A (SAA) is a highly sensitive acute phase reactant that has been linked to inflammatory diseases, both infectious and non-infectious origin. SAA is an apolipoprotein that interacts with HDL, promotes the accumulation of leukocytes at the site of inflammation and the adhesion of platelets, and participates in the removal of damaged cell membranes. The acute phase SAAs (SAA1, SAA2) are transcriptionally regulated in hepatocytes by a variety of inflammatory cytokines, and they can transiently increase > 1000-fold. The combination of SAA, PCT, and CRP can improve the differential diagnosis of early bacterial and viral infections. Several studies indicated that SAA allows monitoring of disease activity in various inflammatory rheumatic diseases and autoinflammatory diseases, including SLE, amyloidosis, or rheumatoid arthritis. SAA can be also used to risk prediction of coronary heart disease, the prognosis of tumour patients, and observation of transplant rejection.

Related Products Docs